[PDF-10.37 MB]
Details:
-
Corporate Authors:
-
Description:In June 1969, a live attenuated rubella virus vaccine was licensed for use in the United States. Subsequently, two other rubella vaccines have been licensed. Thus, rubella vaccine has become available 28 years after the recognition of the etiologic relationship between rubella and congenital rubella syndrome in 1941, 7 years after the isolation of rubella virus in 1962, and 4 years after the first reports of the attenuation of rubella virus. Because considerable experience with these vaccines has accumulated since licensure, it is appropriate to review the available surveillance data.
-
Content Notes:I. Introduction -- II. Recent Trends: A. Source of Data; B. Reported Rubella -- III. Congenital Rubella Syndrome Surveillance -- IV. Biologic Surveillance -- V. Reported Reactions Associated with Administration of Rubella Vaccine: A. Joint reactions; B. Neurological reactions temporally associated with administratin of rubella vaccine. -- VI. Appendix A. Congenital Rubella Syndrome Case Report Form; Appendix B. Serologic Assistance in Rubella Diagnosis; Appendix C. Availability of Rubella Serologic Testing; Appendix D. Recommendations for Use of Rubella Virus Vaacine ; Appendix E. Serologic Testing for Rubella--A warning.
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
